Bavarian Nordic Announces Commercial Launch of Mpox Vaccine in the U.S.
GlobeNewswire
*COPENHAGEN, Denmark, April 2, 2024* – Bavarian Nordic A/S (OMX: BAVA) announced today that JYNNEOS^®, the only FDA-approved..
National Advisory Committee on Immunization
News and Video Search Results
News coverage
-
Moderna Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Updates
Accesswire
-
Older, immunocompromised people may get COVID-19 vaccine dose in spring, NACI says
CTV News
-
Bavarian Nordic Announces Interim Results for the First Nine Months of 2023
GlobeNewswire
-
Influenza Vaccine Market to Expand at a CAGR of 8.7%, Driven by Increasing Efforts and Support From Government, Marketresearch.biz
GlobeNewswire
0 shares
1 views
You might like
National Advisory Committee on Immunization media coverage
Bavarian Nordic’s Mpox Vaccine Receives Recommendation from U.S. CDC Advisory Committee for Routine Use in Adults at Risk
GlobeNewswire
*COPENHAGEN, Denmark, October 25, 2023* – Bavarian Nordic A/S (OMX: BAVA) announced today that the U.S. Centers for Disease..
-
Veopoz™ (pozelimab-bbfg) Receives FDA Approval as the First Treatment for Children and Adults with CHAPLE Disease
GlobeNewswire
-
Press Release: U.S. CDC Advisory Committee unanimously recommends routine use of Beyfortus™ (nirsevimab-alip) to protect infants against RSV disease
GlobeNewswire
-
Press Release: FDA approves Beyfortus™ (nirsevimab-alip) to protect infants against RSV disease
GlobeNewswire
-
Get another COVID-19 booster in the fall, Canada's immunization panel recommends
CP24